Tell the FDA Why New Treatment Options Matter When promising new cancer treatments are denied approval, the impact is felt far beyond a single diagnosis. Patients with all types of cancer—melanoma, breast, lung, pancreatic, ovarian, and more—are left with fewer chances to survive and fewer ways to fight their disease. For many living with advanced cancer, standard therapies work for ... Read More
